(BKMC) BNY Mellon US Mid Cap Core - Ratings and Ratios
Mid-Cap, U.S., Equity, ETF, Derivatives
Dividends
| Dividend Yield | 1.40% |
| Yield on Cost 5y | 2.19% |
| Yield CAGR 5y | 23.65% |
| Payout Consistency | 98.8% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 16.0% |
| Value at Risk 5%th | 26.7% |
| Relative Tail Risk | 1.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -9.80 |
| CAGR/Max DD | 0.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 0.989 |
| Beta Downside | 1.044 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.68% |
| Mean DD | 4.65% |
| Median DD | 3.69% |
Description: BKMC BNY Mellon US Mid Cap Core October 23, 2025
The BNY Mellon US Mid-Cap Core Equity ETF (BKCM) seeks to track a free-float market-cap weighted index of roughly 400 U.S. mid-cap stocks, allocating at least 80% of net assets (plus any investment-purpose borrowings) to those equities, related ETFs, or economically equivalent derivatives. The index is non-diversified, meaning concentration risk can be higher than in broader-market funds.
Key data points (as of Q3 2024): the fund’s expense ratio sits at 0.15%, modest for an actively managed mid-cap vehicle; its weighted average market capitalization is about $7 billion, with the top three sectors-Technology, Industrials, and Health Care-accounting for roughly 45% of holdings. Recent macro drivers include a resilient U.S. consumer spending trend and a still-elevated Federal Reserve policy rate, both of which tend to boost earnings growth in mid-cap firms that are more sensitive to domestic demand cycles.
If you want a deeper, data-rich view of BKMC’s risk-return profile and how it fits into a broader portfolio, ValueRay’s analytics platform offers free, granular tools that can help you validate these observations.
What is the price of BKMC shares?
Over the past week, the price has changed by +0.42%, over one month by +1.91%, over three months by +1.77% and over the past year by +4.31%.
Is BKMC a buy, sell or hold?
What are the forecasts/targets for the BKMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 121.7 | 9.9% |
BKMC Fundamental Data Overview December 03, 2025
Beta = 1.17
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 608.4m USD (608.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 608.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 608.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.66% (E(608.4m)/V(608.4m) * Re(9.66%) + (debt-free company))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BKMC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle